|
Dorsomorphin
Product Overview
Product Name: Dorsomorphin
Alternate Name/Synonyms: 6-[4-(2-Piperidin-1-yl)-ethoxy)-phenyl)]-3-pyridin-4-yl- pyrazolo[1,5-a]-pyrimidine; Compound C
Description: Cell-permeable. A potent, selective , reversible and ATP-competitive inhibitor of AMP-activated protein kinase (AMPK) (Ki = 109 nM in the presence of 5 µM ATP and no AMP). Does not affect the activity on several structurally related kinases including JAK3, PKA, PKCθ, SYK and ZAPK. Also inhibits bone morphogenic protein (BMP) type I receptors (ALK2, ALK3 and ALK6). In addition, recently Dorsomorphin has shown to induce protective autophagy in cancer cells through AMPK inhibition-independent blockade of Akt/mTOR pathway.
Peptide Sequence: N/A
Appearance: Light yellow solid
Formulation: N/A
CAS Number: 866405-64-3
Molecular Formula: C₂₄H₂₅N₅O
Molecular Weight: 399.49
Purity: ≥98% by HPLC
Solubility:DMSO (>5 mg/ml)
Storage Temp.: +4C
Shipping Conditions: RT
Handling: Protect from air and light
SMILES: C1CCN(CC1)CCOC2=CC=C(C=C2)C3=CN4C(=C(C=N4)C5=CC=NC=C5)N=C3
InChi: InChI=1S/C24H25N5O/c1-2-12-28(13-3-1)14-15-30-22-6-4-19(5-7-22)21-16-26-24-23(17-27-29(24)18-21)20-8-10-25-11-9-20/h4-11,16-18H,1-3,12-15H2
InChi Key: XHBVYDAKJHETMP-UHFFFAOYSA-N
PubChem CID: 11524144
MDL Number: MFCD08705402
USAGE: For Research Use Only! Not For Use in Humans. |